Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.1
Accrued Expenses
3 Months Ended
Mar. 31, 2022
Accrued Expenses  
Accrued Expenses

5Accrued Expenses

Accrued expenses consist of the following:

    

March 31, 

    

December 31, 

    

2022

    

2021

Accrued compensation

$

236,851

$

532,678

Accrued interest on preferred members’ interests

 

188,085

 

188,085

Accrued clinical research costs

1,021,220

138,522

Accrued director fees

46,500

31,000

Accrued professional fees

 

41,350

 

24,100

Other miscellaneous accrued expenses

 

12,500

 

7,375

$

1,546,506

$

921,760